Targeting necroptosis: how does exercise protect against metabolic dysfunction-associated fatty liver disease?

Area of Science:

• Hepatology
• Metabolic Diseases
• Cellular Biology

Background:

• Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing global health concern, potentially progressing to severe liver conditions.
• Necroptosis, a form of programmed cell death, is increasingly implicated in MASLD pathogenesis.
• Exercise is known to improve metabolic health and reduce inflammation, key factors in MASLD.

Purpose of the Study:

• To review the current evidence linking necroptosis to MASLD.
• To explore the potential of exercise in modulating necroptosis within the context of MASLD.
• To propose a framework for understanding how exercise might impact MASLD via necroptosis pathways.

Main Methods:

• Literature review of studies on MASLD, necroptosis, and exercise.
• Analysis of proposed molecular pathways (RIPK1/RIPK3, AMPK/mTOR, cGAS/STING).
• Distinguishing between established findings and hypotheses regarding exercise's role.

Main Results:

• Accumulating evidence suggests necroptosis involvement in MASLD development.
• Exercise demonstrates metabolic and anti-inflammatory benefits relevant to MASLD.
• Potential mechanisms for exercise-mediated modulation of necroptosis in MASLD are identified but lack direct experimental validation.

Conclusions:

• A conceptual framework linking exercise, necroptosis, and MASLD is proposed.
• Current understanding relies heavily on indirect evidence and plausible hypotheses.
• Direct experimental validation, especially in hepatic models, is crucial to confirm these links.